Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation ...
Background Conduction system pacing (CSP) has emerged as an alternative to right ventricular pacing (RVP) for ...
The FDA's Circulatory System Devices panel voted 9-2 on Wednesday to recommend approval of the HeartWare Ventricular Assist System as a bridge to heart transplantation for patients with end-stage ...
Adagio Medical Holdings, Inc. ADGM shares are up during Monday’s premarket session following the announcement of positive ...
Cardiac physiologic pacing, also known as cardiac resynchronization therapy, is indicated in patients with heart failure, reduced left ventricular ejection fraction (LVEF) of 50% or less, and either a ...
A novel transcatheter mitral valve replacement system designed for left atrial fixation rather than subvalvular fixation ...
Forty-three cardiology and electrophysiology codes — spanning catheter ablations, coronary revascularization procedures, electrophysiologic evaluations, heart failure management techniques and ...
Adagio Medical reports positive pivotal results for vCLAS Ventricular Ablation System: Laguna Hills, California Tuesday, April 28, 2026, 17:00 Hrs [IST] Adagio Medical Holdings, I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results